Previously treated advanced NSCLC cohort from a multi-disease phase 1 study of ramucirumab (R) plus pembrolizumab (P): Efficacy and safety data

Affiliation auteurs!!!! Error affiliation !!!!
TitrePreviously treated advanced NSCLC cohort from a multi-disease phase 1 study of ramucirumab (R) plus pembrolizumab (P): Efficacy and safety data
Type de publicationJournal Article
Year of Publication2017
AuteursHerbst R.S, Martin-Liberal J., Calvo E., Isambert N., Bendell J., Cassier P., Jin J., Mi G., Rege J., Paz-Ares L.
JournalANNALS OF ONCOLOGY
Volume28
Date PublishedAPR
Type of ArticleMeeting Abstract
ISSN0923-7534